Fig. 1From: Temporal and geographical external validation study and extension of the Mayo Clinic prediction model to predict eGFR in the younger population of Swiss ADPKD patientsSubclassification of ADPKD patients based on HtTKV limits on their age at baseline. Limits are defined from the Mayo Clinic based on estimated kidney growth rates of <1.5% (dark green), 1.5–3.0% (mint), 3–4.5% (yellow), 4.5–6% (orange) and >6% (red)Back to article page